Opening book details…
About this Medicine article
First-line pembrolizumab (pembro) monotherapy for advanced non-clear cell renal cell carcinoma (nccRCC): Updated follow-up for KEYNOTE-427 cohort B by Suárez, C; Lee, J-L; Ziobro, M; Gafanov, R A; Matveev, V B; Donskov, F; Pouliot, F; Alekseev, B Y; Wiechno, P J; Tomczak, P; Climent, M A; Shin, S J; Kloss Silverman, R; Perini, R F; Schloss, C; McDermott, D F; Atkins, M B is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Suárez, C; Lee, J-L; Ziobro, M; Gafanov, R A; Matveev, V B; Donskov, F; Pouliot, F; Alekseev, B Y; Wiechno, P J; Tomczak, P; Climent, M A; Shin, S J; Kloss Silverman, R; Perini, R F; Schloss, C; McDermott, D F; Atkins, M B
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2019
- Field
- Medicine (Health Sciences)